Savara Inc (SVRA) stock
SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.72+0.24 (+5.36%)
Close on Nov 18, 2026Market cap $969.77MP/E –Yield –
Savara price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Savara's price to sales ratio was 400.4× on Apr 30, 2021, against 310.4× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 400.4× | +157.2 |
| 2020 | Dec 31, 2020 | 243.2× | +204.5 |
| 2017 | Jul 31, 2017 | 38.7× | −165.4 |
| 2016 | Dec 30, 2016 | 204.1× | – |
See a number that looks wrong?